Announcement
·
06 May 2025
·
M42 appoints Dimitris Moulavasilis as Group CEO

Bridging AI, Genomics, and Biotech: Unlocking Precision Medicine

25 April 2025
Genomics and Precision Medicine
Abu Dhabi Global Healthcare Week 2025

About the Speakers

  • Dr. David Bearss
    CEO Halia Theraperutics
  • Dr. Ronnie Rajan
    Vice President, AI & Applied Sciences, M42
  • Albarah El Khani
    Senior Director of Operations at M42
  • Paul Jones
    Chief Executive Officer, Omics Centre of Excellence

    Paul Jones, CEO of M42’s Omics Centre of Excellence, drives advancements in genomics and precision medicine with 30+ years of experience in global genomic programs and personalized health solutions.

  • Islam Eltantawy
    General Director for IROS

    Watch Next